GPFT (Grapefruit USA) EV-to-EBIT: -3.04 (As of Jul. 20, 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is Grapefruit USA EV-to-EBIT?

Grapefruit USA GPFT +10.00% EV-to-EBIT is -3.04 as of Jul. 20, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Grapefruit USA's Enterprise Value is $0.33 Mil. Grapefruit USA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.11 Mil. Therefore, Grapefruit USA's EV-to-EBIT for today is -3.04.

The historical rank and industry rank for Grapefruit USA's EV-to-EBIT or its related term are showing as below:

GPFT's EV-to-EBIT is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Grapefruit USA's Enterprise Value for the quarter that ended in Sep. 2023 was $7.43 Mil. Grapefruit USA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.11 Mil. Grapefruit USA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -1.44%.

Grapefruit USA (OTCPK:GPFT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Grapefruit USA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 )	=	EBIT	/	Enterprise Value (Q: Sep. 2023 )
	=	-0.107	/	7.4332802
	=	-1.44 %

Grapefruit USA's Enterprise Value for the quarter that ended in Sep. 2023 was $7.43 Mil.
Grapefruit USA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grapefruit USA EV-to-EBIT Related Terms

Grapefruit USA EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Grapefruit USA's EV-to-EBIT can be seen below:

Grapefruit USA EV-to-EBIT Chart

Grapefruit USA Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EV-to-EBIT

Get a 7-Day Free Trial

1.03

-0.40

-9.17

-24.35

-4.24

Grapefruit USA Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Sep23
EV-to-EBIT	Get a 7-Day Free Trial															-4.24	-6.93	-4.98	-3.88	-69.47

GPFT vs KAYS, KOAN, MJNE: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grapefruit USA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grapefruit USA EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grapefruit USA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Grapefruit USA's EV-to-EBIT falls into.

Save Embed

Grapefruit USA EV-to-EBIT Calculation

Grapefruit USA's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.325	/	-0.107
	=	-3.04

Grapefruit USA's current Enterprise Value is $0.33 Mil.
Grapefruit USA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11 Mil.

Frequently Asked Questions Learn more about EV-to-EBIT →

What does a EV-to-EBIT of -3.04 mean?

Grapefruit USA (GPFT) has a EV-to-EBIT of -3.04 as of Jul. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Grapefruit USA and its competitors.

Is Grapefruit USA's EV-to-EBIT too high?

Grapefruit USA's current EV-to-EBIT is -3.04.

How does Grapefruit USA's EV-to-EBIT compare to KAYS and KOAN?

Grapefruit USA's EV-to-EBIT of -3.04 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 16.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EV-to-EBIT for a Drug Manufacturers company?

The median EV-to-EBIT among Drug Manufacturers companies is 16.00, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EV-to-EBIT mean?

A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Grapefruit USA and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 16.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grapefruit USA's current EV-to-EBIT is -3.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Grapefruit USA stock overvalued right now?

Grapefruit USA (GPFT) has a current EV-to-EBIT of -3.04. The current EV-to-EBIT is -3.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EV-to-EBIT calculated?

EV-to-EBIT is calculated from a company's financial statements. For Grapefruit USA (GPFT), the current EV-to-EBIT is -3.04 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grapefruit USA Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies KAYS KOAN MJNE LRSV CSTF STMH KGKG CBDY CANB GCAN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX

Address 10850 Wilshire Boulevard, Suite 710, Los Angeles, CA, USA, 90024

Website https://www.grapefruitblvd.com

Grapefruit USA Inc currently has no operations. It is actively seeking a strategic merger partner with the goal of completing a business combination.